Cargando…

Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study

OBJECTIVES: We explored whether genetically predicted increased body mass index (BMI) modulates multiple sclerosis (MS) risk through interleukin-6 (IL-6) signaling. METHODS: We performed a two-sample Mendelian randomization (MR) study using multiple genome-wide association studies (GWAS) datasets fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vandebergh, Marijne, Becelaere, Sara, Dubois, Bénédicte, Goris, An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978959/ https://www.ncbi.nlm.nih.gov/pubmed/35386698 http://dx.doi.org/10.3389/fimmu.2022.834644

Ejemplares similares

Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis: A Mendelian Randomization Study
por: Vandebergh, Marijne, et al.
Publicado: (2022)

Smoking and multiple sclerosis risk: a Mendelian randomization study
por: Vandebergh, Marijne, et al.
Publicado: (2020)

Quantitative MRI phenotypes capture biological heterogeneity in multiple sclerosis patients
por: Smets, Ide, et al.
Publicado: (2021)

CHIT1 at Diagnosis Reflects Long‐Term Multiple Sclerosis Disease Activity
por: Oldoni, Emanuela, et al.
Publicado: (2020)

Genetic Variation in WNT9B Increases Relapse Hazard in Multiple Sclerosis
por: Vandebergh, Marijne, et al.
Publicado: (2021)

Frequent somatic mosaicism in T lymphocyte subsets in individuals with and without multiple sclerosis
por: Van Horebeek, Lies, et al.
Publicado: (2022)

Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study
por: Lu, Hui, et al.
Publicado: (2021)

Progress in Multiple Sclerosis Genetics
por: Goris, An, et al.
Publicado: (2012)

Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis
por: Smets, Ide, et al.
Publicado: (2021)

Multiple Sclerosis and the Risk of Cardiovascular Diseases: A Mendelian Randomization Study
por: Yang, Fangkun, et al.
Publicado: (2022)

Physical activity and risk of multiple sclerosis: A Mendelian randomization study
por: Li, Chunyu, et al.
Publicado: (2022)

Natural Killer Cells in Multiple Sclerosis: Entering the Stage
por: Beliën, Jarne, et al.
Publicado: (2022)

Inflammatory bowel diseases, interleukin-6 and interleukin-6 receptor subunit alpha in causal association with cerebral cortical structure: a Mendelian randomization analysis
por: Liu, Chunlong, et al.
Publicado: (2023)

Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort
por: Manni, Alessia, et al.
Publicado: (2019)

The Effect of Peripheral Immune Cell Counts on the Risk of Multiple Sclerosis: A Mendelian Randomization Study
por: He, Di, et al.
Publicado: (2022)

Downregulation of interleukin 6 signaling might reduce the risk of periodontitis: a drug target Mendelian randomization study
por: Nolde, Michael, et al.
Publicado: (2023)

A causal relationship between leukocyte telomere length and multiple sclerosis: A Mendelian randomization study
por: Liao, Qiao, et al.
Publicado: (2022)

Body mass index and psychiatric disorders: a Mendelian randomization study
por: Hartwig, Fernando Pires, et al.
Publicado: (2016)

Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study
por: Yuan, Shuai, et al.
Publicado: (2023)

Interleukin-17 and inflammatory bowel disease: a 2-sample Mendelian randomization study
por: Cai, Yangke, et al.
Publicado: (2023)

Body mass index and breast cancer survival: a Mendelian randomization analysis
por: Guo, Qi, et al.
Publicado: (2017)

Body mass index and colorectal cancer risk: A Mendelian randomization study
por: Suzuki, Shiori, et al.
Publicado: (2021)

Body Mass Index and the Risk of Atrial Fibrillation: A Mendelian Randomization Study
por: Ma, Mi, et al.
Publicado: (2022)

Epstein-Barr virus, interleukin-10 and multiple sclerosis: A ménage à trois
por: Schönrich, Günther, et al.
Publicado: (2022)

Association of Pre-Disease Body Mass Index With Multiple Sclerosis Prognosis
por: Manouchehrinia, Ali, et al.
Publicado: (2018)

Association between inflammatory bowel disease and interleukins, chemokines: a two-sample bidirectional mendelian randomization study
por: Fang, Guojiu, et al.
Publicado: (2023)

Causal association of body mass index with hypertension using a Mendelian randomization design
por: Lee, Mee-Ri, et al.
Publicado: (2018)

The Association Between Increment of Interleukin-1 and Interleukin-6 in Women with Polycystic Ovary Syndrome and Body Mass Index
por: Mazloomi, Sahar, et al.
Publicado: (2023)

Body Mass Index in Multiple Sclerosis: Associations with CSF Neurotransmitter Metabolite Levels
por: Markianos, Manolis, et al.
Publicado: (2013)

Age-specific effects of childhood body mass index on multiple sclerosis risk
por: Hone, Luke, et al.
Publicado: (2022)

Sleep status in multiple sclerosis: Role of vitamin D and body mass index
por: Yazdchi, Mohammad, et al.
Publicado: (2022)

Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis
por: Li, Liya, et al.
Publicado: (2018)

IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis
por: Zheng, Yang, et al.
Publicado: (2020)

The effect of body mass index on smoking behaviour and nicotine metabolism: a Mendelian randomization study
por: Taylor, Amy E, et al.
Publicado: (2019)

Body mass index and the risk of basal cell carcinoma: evidence from Mendelian randomization analysis
por: Lu, Likui, et al.
Publicado: (2023)

Causal association between body mass index and autoimmune thyroiditis: evidence from Mendelian randomization
por: Huo, Jinlong, et al.
Publicado: (2023)

Bidirectional two-sample Mendelian randomization analysis reveals a causal effect of interleukin-18 levels on postherpetic neuralgia risk
por: Liang, Xiao, et al.
Publicado: (2023)

Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study
por: Budu-Aggrey, Ashley, et al.
Publicado: (2019)

Obesity and Multiple Sclerosis: A Mendelian Randomization Study
por: Mokry, Lauren E., et al.
Publicado: (2016)

Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1
por: Dufour, Aleksandra Maria, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_12ir2lt8qnqbme8noar13q5v3s